Tran, T. H., Nguyen, J. V., Stecula, A., Akutagawa, J., Moorman, A. V., Braun, B. S., Sali, A., Mullighan, C. G., Shah, N. P., Dai, Y., Devidas, M., Roberts, K. G., Smith, C. C. and Loh, M. L. (2021) “The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i&gt; and detectable in clinical samples prior to treatment”, Haematologica. Pavia, Italy, 106(8), pp. 2242-2245. doi: 10.3324/haematol.2020.261354.